| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 2,357,000 | 2,734,000 | 2,890,000 | 2,869,000 | | Cost of Revenue | 1,929,000 | 2,812,000 | 1,753,000 | 2,120,000 | | | Gross Profit | 428,000 | (78,000) | 1,137,000 | 749,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 328,000 | (301,000) | 898,000 | 396,000 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 150,000 | 154,000 | 152,000 | 148,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (50,000) | 69,000 | 87,000 | 205,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (19,000) | (122,000) | (263,000) | 350,000 | | Earnings Before Interest And Taxes | (69,000) | (53,000) | (176,000) | 555,000 | | Interest Expense | 38,000 | 30,000 | 29,000 | 26,000 | | Income Before Tax | (107,000) | (83,000) | (205,000) | 529,000 | | Income Tax Expense | (16,000) | (27,000) | (84,000) | 208,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (91,000) | (56,000) | (121,000) | 321,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (91,000) | (56,000) | (121,000) | 321,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($91,000) | ($56,000) | ($121,000) | $321,000 |
|
0.45% Nasdaq 
0.20%
Income Statement
